Abstract
Isosteviol is a beyerane tetracyclic diterpenoid with a large variety of biological activities. In this article, a series of novel isosteviol derivatives containing the modification of C-18 carboxyl group (5-12), C-16 carbonyl group (14- 16) and heteroatom-containing frameworks fused with isosteviol structure (18-19) were synthesized and evaluated for their in vivo acute antihyperglycemeric effects. Among them, compound 8 exhibited the most potent antihyperglycemeric effects. Furthermore, primarily, structure-activity relationship (SAR) was also analyzed. The structures of all the newly synthesized compounds were determined by 1H, 13CNMR, MS, IR and elementary analysis.
Keywords: Isosteviol, Derivatives, Synthesis, Acute antihyperglycemeric, Antihyperglycemic, Isosteviol Derivatives, Beyerane tetracyclic diterpenoid, Antihyperglycemeric effects, Structure-activity relationship (SAR), Noncaloric sugar, Antitumor, Antihypertension, Anti-inflammatory, Glucocorticoid agonist, Antiproliferation, Anti-diabetic, Pharmacokinetic research, Glucuronic acid, Structure acitity relationship (SAR), (IVGTT), Antihyperglycemeric effect, Drug rosiglitazone maleate, Blood glucose level
Letters in Drug Design & Discovery
Title: Synthesis and In Vivo Acute Antihyperglycemic Evaluation of Novel Isosteviol Derivatives
Volume: 7 Issue: 9
Author(s): Junqing Chen, Xiaoming Zha, Min Sun, Jin Cai, Wen Zhou and Min Ji
Affiliation:
Keywords: Isosteviol, Derivatives, Synthesis, Acute antihyperglycemeric, Antihyperglycemic, Isosteviol Derivatives, Beyerane tetracyclic diterpenoid, Antihyperglycemeric effects, Structure-activity relationship (SAR), Noncaloric sugar, Antitumor, Antihypertension, Anti-inflammatory, Glucocorticoid agonist, Antiproliferation, Anti-diabetic, Pharmacokinetic research, Glucuronic acid, Structure acitity relationship (SAR), (IVGTT), Antihyperglycemeric effect, Drug rosiglitazone maleate, Blood glucose level
Abstract: Isosteviol is a beyerane tetracyclic diterpenoid with a large variety of biological activities. In this article, a series of novel isosteviol derivatives containing the modification of C-18 carboxyl group (5-12), C-16 carbonyl group (14- 16) and heteroatom-containing frameworks fused with isosteviol structure (18-19) were synthesized and evaluated for their in vivo acute antihyperglycemeric effects. Among them, compound 8 exhibited the most potent antihyperglycemeric effects. Furthermore, primarily, structure-activity relationship (SAR) was also analyzed. The structures of all the newly synthesized compounds were determined by 1H, 13CNMR, MS, IR and elementary analysis.
Export Options
About this article
Cite this article as:
Chen Junqing, Zha Xiaoming, Sun Min, Cai Jin, Zhou Wen and Ji Min, Synthesis and In Vivo Acute Antihyperglycemic Evaluation of Novel Isosteviol Derivatives, Letters in Drug Design & Discovery 2010; 7 (9) . https://dx.doi.org/10.2174/157018010792929522
DOI https://dx.doi.org/10.2174/157018010792929522 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Xanthan and Locust Bean Gum (from Ceratonia siliqua) Matrix Tablets for Oral Controlled Delivery of Metoprolol Tartrate
Current Drug Therapy Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches
Current Pharmaceutical Biotechnology Effectiveness of Nasal Continuous Positive Airway Pressure (CPAP) Therapy on Cardiovascular Outcomes in Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
Current Respiratory Medicine Reviews Extended-release Formulation Attenuates the Impacts of Fluvastatin on Serum PCSK9 Levels in Humans
Letters in Drug Design & Discovery Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?
Current Pharmaceutical Design DNA Methylation, An Epigenetic Mode of Gene Expression Regulation in Reproductive Science
Current Pharmaceutical Design Pharmacological Effects of Biotin in Animals
Mini-Reviews in Medicinal Chemistry Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Preface: Vitamin D and QT Interval in Epilepsy: More than an Association?
Current Clinical Pharmacology Clinical Approach for the Treatment of Obesity-associated Diseases
Current Pharmaceutical Design Impact of Sex Hormone Metabolism on the Vascular Effects of Menopausal Hormone Therapy in Cardiovascular Disease
Current Drug Metabolism The Use of Biomarkers for Assessing HAART-Associated Renal Toxicity in HIV-Infected Patients
Current HIV Research Poor Nutrition with Aging: an “Oxidatively Stressing” Condition
Current Nutrition & Food Science Amphetamine-Type Medicines: A Review of Pharmacokinetics, Pharmacodynamics, and Toxicological Aspects.
Current Clinical Pharmacology A Pharmacological Review of Five Widely Used Traditional Medicinal Plants for Sedative-Hypnotic Effects in Bangladesh
Current Traditional Medicine Adynamic Ileus Induced by Varenicline
Current Drug Safety Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery Analgesia in PACU: Nonsteroidal Anti-Inflammatory Drugs
Current Drug Targets Possible Links of Age Related Hypertension and Evolution Imposed Features of Heart and Aorta
Current Aging Science